Agilent showcases cancer research solutions at AACR 2026

Agilent (A) Technologies will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research Annual Meeting on April 17-22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and companion diagnostics development, reflecting the growing demand for more integrated approaches across the cancer research continuum. Among the technologies featured is the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation series of cell imaging and multimode microplate readers. Cytation 9 is designed to support advanced live-cell and endpoint assays by combining automated microscopy with conventional microplate reading in a single system, supporting a range of cell-based research applications. In addition, Agilent will provide an early preview of the upcoming AI-enabled software enhancement for the xCELLigence RTCA eSight, designed to bring the same straightforward, objective data analysis long valued in impedance measurements to label-free live-cell imaging, while supporting more consistent, reproducible results. AACR attendees are invited to join Agilent at the Exhibitor Spotlight Theater for a session titled “Direct Targeted Methylation Sequencing with SureSelect: Targeted Long-Read Sequencing for Native Variant and Methylation Profiling in Oncology.” The session will be presented by Andrew Jenkins, biotechnology research associate at Wasatch Biolabs, and will examine the use of targeted long-read sequencing approaches in oncology research. Agilent will also highlight its collaboration with Oxford Nanopore Technologies, demonstrating the compatibility of Agilent SureSelect target enrichment chemistry with ONT’s long-read sequencing platforms. By integrating SureSelect libraries into ONT sequencing workflows, researchers can pair hybrid-capture target enrichment with real-time, long-read sequencing to support applications such as target genomics, structural variant analysis, and methylation profiling. Immediately preceding AACR 2026, Agilent’s xCELLigence User Group Meeting will bring together the real-time cell analysis community to share best practices, applications, and real-world insights from functional cell-based research.